Q10064: P. Schiapparelli, et al. Strategies to Modulate the Blood-Brain Barrier for Directed Brain Tumor Targeting.
Nanotherapy for Brain Tumor Drug Delivery 2021;
Agents: Not Stated Vehicle: Saline, sterile; Route: CSF/CNS; Species: Mice; Pump: 1007D; Duration: 7 days;
ALZET Comments: 0.9% NaCl used; animal info (6-8-week-old mice); ALZET brain infusion kit 3 used; cancer (Brain Tumor);
Q10280: S. Pietzsch, et al. Anthracycline-free tumor elimination in mice leads to functional and molecular cardiac recovery
from cancer-induced alterations in contrast to long-lasting doxorubicin treatment effects. Basic Research in Cardiology
2021;116(1):61
Agents: Angiotensin II Vehicle: PBS; Route: Not Stated; Species: Mice; Pump: Not Stated; Duration: 14 days;
ALZET Comments: Dose (1.44 ug/g BW); dose-response (examines tolerance to increased blood pressure by continuous AngII
infusion shown in fig. 3C on pg 61); Controls received mp w/ GCV-m+AngII; animal info (male mice ~12 weeks, housed in
groups of 5 and maintained on a 14 h/10 h light/dark cycle); Resultant plasma level (found carnitine reduction in plasma
samples during advanced cancer stage but normalization after recovery); peptides; cancer (cardiac); cardiovascular;